Business
LENSAR Reports First Quarter 2025 Results and Provides Business Update
14 ALLY Robotic Laser Cataract Systems™ (“ALLY Systems”) placed in 1Q 2025 with an additional backlog of 24 systems pending installation as of March 31, 2025 34% Revenue growth over the first quarter 2024 and 22% Recurring revenue growth in the trailing twelve months Worldwide procedure volumes increased 33% over the first quarter of 2024 ORLANDO, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company), a global medical technology company focused on advanced
About this update from Lensar, Inc.
[{"type":"image","alt":"LENSAR, Inc.","displaySize":"","headline":null,"caption":"LENSAR, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":93,"url":"https://media.zenfs.com/en/globenewswire.com/d1c1b88485f9d6b84f0bcc4f01761fab"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/5m4XdjtA1TWabMYxLZPKag--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/d1c1b88485f9d6b84f0bcc4f01761fab","width":300,"height":93}},"lazy":false},{"type":"text","content":" 14 ALLY Robotic Laser Cataract Systems™ (“ALLY Systems”) placed in 1Q 2025 with an additional backlog of 24 systems pending installation as of March 31, 2025","length":185,"tagName":"p"},{"type":"text","content":"34% Revenue growth over the first quarter 2024 and 22% Recurring revenue growth in the trailing twelve months","length":109,"tagName":"p"},{"type":"text","content":"Worldwide procedure volumes increased 33% over the first quarter of 2024 ","length":72,"tagName":"p"},{"type":"text","content":"ORLANDO, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended March 31, 2025 and provided an update on key operational initiatives.","length":341,"tagName":"p"},{"type":"text","content":"“We had a solid start to 2025, as we successfully placed 40% more ALLY Systems in the first quarter of 2025, compared to the first quarter of 2024. Similarly, we achieved a substantial 34% increase in revenue and our worldwide procedure volumes were 33% above first quarter 2024 levels. Over the quarter, we began to see the positive impact of the ALLY Systems placed in the latter half of 2024 as they contributed to significantly higher procedure volume and recurring revenue year over year,” said Nick Curtis, President and CEO of LENSAR.","length":541,"tagName":"p"},{"type":"text","content":"First Quarter 2025 Financial Results ","length":36,"tagName":"p"},{"type":"text","content":"Total revenue for the quarter ended March 31, 2024 was $14.2 million, an increase of $3.6 million, or 34%, compared to total revenue of $10.6 million for the quarter ended March 31, 2024. The increase in the first quarter of 2025 w...